philboss game
Tulane QB Mensah transfers to Duke
Tweet Facebook Mail A new blood test developed by scientists in Melbourne could detect melanomas before they're even visible to the naked eye. About 2000 Australians are killed by skin cancer each year but a new research breakthrough could save countless lives from the deadly disease. The blood tests measure the biomarker of cancer and can identify melanoma before symptoms are shown on the skin. READ MORE: Man, 31, charged with double murder of married Sydney couple The blood test could be available to patients by 2025. (9News) The researchers say the method has a 97 per cent accuracy rate when determining between benign and different stages of melanoma. If the blood test is given the green light by the regulator, it could be available to use within the next six months. It is expected to be available at some point next year. But it will not come cheap; 9News understands that it is not covered by the government, meaning it could cost patients between $1200 and $1500 per test. READ MORE: Tobacco shop destroyed in suspicious blaze Melanoma is the third most common cancer in Australia. (9News) The technology was developed alongside inventor Genesq Biosciences and pathology provider Australian Clinical Labs (ACL). Melanoma is the third most common cancer in Australia and is the most common for Australians aged between 20 and 39. About 90 per cent of melanomas can be cured by surgery if caught early. DOWNLOAD THE 9NEWS APP : Stay across all the latest in breaking news, sport, politics and the weather via our news app and get notifications sent straight to your smartphone. Available on the Apple App Store and Google Play .
Biden gives life in prison to 37 of 40 federal death row inmates before Trump can resume executionsPathstone Holdings LLC reduced its holdings in shares of FactSet Research Systems Inc. ( NYSE:FDS – Free Report ) by 1.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,118 shares of the business services provider’s stock after selling 146 shares during the quarter. Pathstone Holdings LLC’s holdings in FactSet Research Systems were worth $3,733,000 at the end of the most recent quarter. Several other large investors also recently made changes to their positions in the business. Gabelli Funds LLC boosted its position in FactSet Research Systems by 16.7% during the 1st quarter. Gabelli Funds LLC now owns 700 shares of the business services provider’s stock worth $318,000 after purchasing an additional 100 shares during the period. Kennedy Capital Management LLC lifted its stake in shares of FactSet Research Systems by 10.8% during the first quarter. Kennedy Capital Management LLC now owns 26,856 shares of the business services provider’s stock worth $12,203,000 after purchasing an additional 2,622 shares in the last quarter. B. Riley Wealth Advisors Inc. boosted its position in shares of FactSet Research Systems by 53.1% in the first quarter. B. Riley Wealth Advisors Inc. now owns 744 shares of the business services provider’s stock worth $325,000 after buying an additional 258 shares during the period. Tidal Investments LLC grew its stake in shares of FactSet Research Systems by 225.1% in the first quarter. Tidal Investments LLC now owns 2,344 shares of the business services provider’s stock valued at $1,065,000 after buying an additional 1,623 shares in the last quarter. Finally, Hancock Whitney Corp raised its holdings in shares of FactSet Research Systems by 3.0% during the 1st quarter. Hancock Whitney Corp now owns 28,646 shares of the business services provider’s stock valued at $13,016,000 after buying an additional 828 shares during the period. Institutional investors and hedge funds own 91.24% of the company’s stock. Insider Buying and Selling In other news, CEO Frederick Philip Snow sold 3,000 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $416.59, for a total transaction of $1,249,770.00. Following the completion of the transaction, the chief executive officer now owns 12,915 shares in the company, valued at approximately $5,380,259.85. This represents a 18.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website . Also, insider John Costigan sold 1,622 shares of FactSet Research Systems stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $481.00, for a total transaction of $780,182.00. Following the completion of the sale, the insider now owns 299 shares in the company, valued at approximately $143,819. This represents a 84.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here . Insiders sold a total of 26,984 shares of company stock worth $12,230,877 in the last three months. 1.10% of the stock is owned by insiders. Wall Street Analysts Forecast Growth Read Our Latest Report on FDS FactSet Research Systems Stock Up 0.4 % Shares of NYSE:FDS opened at $487.62 on Friday. The company’s fifty day moving average is $466.05 and its two-hundred day moving average is $435.59. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.25 and a current ratio of 1.25. FactSet Research Systems Inc. has a 1-year low of $391.84 and a 1-year high of $499.87. The stock has a market capitalization of $18.52 billion, a price-to-earnings ratio of 35.08, a price-to-earnings-growth ratio of 3.12 and a beta of 0.75. FactSet Research Systems ( NYSE:FDS – Get Free Report ) last released its quarterly earnings data on Thursday, September 19th. The business services provider reported $3.74 earnings per share for the quarter, topping the consensus estimate of $3.62 by $0.12. FactSet Research Systems had a net margin of 24.38% and a return on equity of 34.77%. The firm had revenue of $562.20 million for the quarter, compared to analyst estimates of $547.06 million. During the same quarter in the prior year, the business earned $2.93 earnings per share. FactSet Research Systems’s quarterly revenue was up 4.9% on a year-over-year basis. Equities analysts anticipate that FactSet Research Systems Inc. will post 17.2 EPS for the current year. FactSet Research Systems Announces Dividend The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Friday, November 29th will be given a dividend of $1.04 per share. The ex-dividend date of this dividend is Friday, November 29th. This represents a $4.16 dividend on an annualized basis and a yield of 0.85%. FactSet Research Systems’s dividend payout ratio is currently 29.93%. FactSet Research Systems Company Profile ( Free Report ) FactSet Research Systems Inc, a financial data company, provides integrated financial information and analytical applications to the investment community in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company delivers insight and information through the workflow solutions of research, analytics and trading, content and technology solutions, and wealth. Further Reading Receive News & Ratings for FactSet Research Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FactSet Research Systems and related companies with MarketBeat.com's FREE daily email newsletter .